• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prognostic factors for the outcome of methotrexate treatment in rheumatoid arthritis.

作者信息

Kolarz G, Mayrhofer F, Peichl P, Posch E, Scherak O, Singer F, Thumb N, Wottawa A

机构信息

Institute for Rheumatology, Baden, Austria.

出版信息

Clin Rheumatol. 1995 Sep;14(5):515-8. doi: 10.1007/BF02208147.

DOI:10.1007/BF02208147
PMID:8549088
Abstract
摘要

相似文献

1
Prognostic factors for the outcome of methotrexate treatment in rheumatoid arthritis.类风湿关节炎中甲氨蝶呤治疗结果的预后因素
Clin Rheumatol. 1995 Sep;14(5):515-8. doi: 10.1007/BF02208147.
2
Safety of combination therapy with hydroxychloroquine, gold sodium thiomalate and methotrexate in early rheumatoid arthritis.羟氯喹、硫代苹果酸金钠与甲氨蝶呤联合治疗早期类风湿性关节炎的安全性
Rev Rhum Engl Ed. 1997 Jul-Sep;64(7-9):521-2.
3
Therapeutic benefits of irsogladine maleate on aphthous stomatitis induced by methotrexate in rheumatoid arthritis.马来酸伊索拉定对类风湿关节炎患者甲氨蝶呤所致口腔溃疡的治疗作用
J Rheumatol. 2003 Sep;30(9):2082-3.
4
The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression.在未使用甲氨蝶呤且预后因素较差的早期类风湿性关节炎患者中开展的第一项关于赛妥珠单抗聚乙二醇化修饰物的双盲、随机、平行组研究——C-OPERA研究，显示出对影像学进展的抑制作用。
Ann Rheum Dis. 2016 Jan;75(1):75-83. doi: 10.1136/annrheumdis-2015-207511. Epub 2015 Jul 2.
5
Prospective long term follow-up of methotrexate therapy in rheumatoid arthritis: toxicity, efficacy and radiological progression.
Br J Rheumatol. 1989 Apr;28(2):147-53. doi: 10.1093/rheumatology/28.2.147.
6
Cytomegalovirus pneumonia in a rheumatoid arthritis patient on low dose methotrexate.一名类风湿关节炎患者在接受低剂量甲氨蝶呤治疗时发生巨细胞病毒肺炎。
J Assoc Physicians India. 1998 Jun;46(6):554-6.
7
Long-term followup of patients receiving combined therapy with cyclosporine and methotrexate.
Arthritis Rheum. 1998 Sep;41(9):1703-4. doi: 10.1002/1529-0131(199809)41:9<1703::AID-ART25>3.0.CO;2-D.
8
Colchicine therapy for low-dose-methotrexate-induced accelerated nodulosis in a rheumatoid arthritis patient.秋水仙碱治疗类风湿关节炎患者低剂量甲氨蝶呤诱发的加速性结节病
J Dermatol. 1999 Oct;26(10):691-4. doi: 10.1111/j.1346-8138.1999.tb02074.x.
9
The effects of methotrexate on interleukin 1 in patients with rheumatoid arthritis.甲氨蝶呤对类风湿关节炎患者白细胞介素1的影响。
J Rheumatol. 1992 Nov;19(11):1678-82.
10
Methotrexate therapy in rheumatoid arthritis: 2-year retrospective followup study.
J Rheumatol. 1989 Mar;16(3):307-12.

本文引用的文献

1
Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy.类风湿关节炎患者循环中可溶性肿瘤坏死因子受体、白细胞介素-2受体、肿瘤坏死因子α及白细胞介素-6水平。甲氨蝶呤和硫唑嘌呤治疗期间的纵向评估。
Arthritis Rheum. 1993 Aug;36(8):1070-9. doi: 10.1002/art.1780360807.
2
The effects of methotrexate on soluble interleukin-2 receptor levels in rheumatoid arthritis: comment on the article by Barrera et al.甲氨蝶呤对类风湿关节炎患者可溶性白细胞介素-2受体水平的影响：对巴雷拉等人文章的评论
Arthritis Rheum. 1994 Apr;37(4):597-9. doi: 10.1002/art.1780370426.
3
Interleukin-2 receptor levels in the sera of rheumatoid arthritis patients treated with methotrexate.
用甲氨蝶呤治疗的类风湿关节炎患者血清中的白细胞介素-2受体水平。
Arthritis Rheum. 1994 Jan;37(1):50-6. doi: 10.1002/art.1780370108.
4
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.美国风湿病协会1987年修订的类风湿关节炎分类标准。
Arthritis Rheum. 1988 Mar;31(3):315-24. doi: 10.1002/art.1780310302.
5
[Methotrexate therapy of chronic polyarthritis].[甲氨蝶呤治疗慢性多关节炎]
Dtsch Med Wochenschr. 1987 Jul 10;112(28-29):1142-7. doi: 10.1055/s-2008-1068211.
6
Methotrexate in rheumatoid arthritis.
Arthritis Rheum. 1988 Mar;31(3):305-14. doi: 10.1002/art.1780310301.
7
Prospective long term follow-up of methotrexate therapy in rheumatoid arthritis: toxicity, efficacy and radiological progression.
Br J Rheumatol. 1989 Apr;28(2):147-53. doi: 10.1093/rheumatology/28.2.147.
8
Comparative controlled trial of low-dose weekly methotrexate versus azathioprine in rheumatoid arthritis: 3-year prospective study.
Br J Rheumatol. 1990 Apr;29(2):120-5. doi: 10.1093/rheumatology/29.2.120.
9
Presence of NAP-1/IL-8 in synovial fluids indicates a possible pathogenic role in rheumatoid arthritis.滑液中存在NAP-1/IL-8表明其在类风湿性关节炎中可能具有致病作用。
Scand J Immunol. 1991 Sep;34(3):333-9. doi: 10.1111/j.1365-3083.1991.tb01554.x.
10
Analysis of methotrexate treatment effect in a longitudinal observational study: utility of cluster analysis.纵向观察研究中氨甲蝶呤治疗效果分析：聚类分析的效用
J Rheumatol. 1991 May;18(5):672-7.